STOCK TITAN

IQVIA Launches New Grants/Funding Management Module for Its Orchestrated Customer Engagement Platform

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

IQVIA (NYSE:IQV) has launched a new module, Grants and Funding Management, within its Orchestrated Customer Engagement (OCE) solutions. This module aims to provide life sciences companies a comprehensive tool to manage their global strategic giving programs, from grant submission to payment processing. The automated system enhances user experience and compliance, helping to streamline workflows and reduce errors. IQVIA continues to leverage its expertise to adapt to evolving market needs, promoting efficiency in funding request management.

Positive
  • Launch of Grants and Funding Management module aimed at enhancing user experience and compliance.
  • Automated workflows reduce errors and streamline grant management processes.
  • Expands IQVIA's offerings in the engagement management space.
Negative
  • None.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced the launch of Grants and Funding Management, new module within the Orchestrated Customer Engagement (OCE) solutions portfolio. From grant submission to payment processing and closeout, IQVIA Grants and Funding Management provides life sciences companies with a solution to efficiently manage and oversee their global strategic giving programs.

“IQVIA Technologies is excited to announce our latest offering, built to transform funding request management for life sciences companies through its advanced user interface (UI) and automated end-to-end workflows,” said Michael Utell, vice president, IQVIA Commercial Compliance. “For over 15 years we have been at the forefront of grants management, driven by our deep understanding of its impact and intricacy. Expanding our focus to user experience and outcomes is essential in addressing the market needs.”

Built on IQVIA’s Orchestrated Customer Engagement Platform, the Grants and Funding Management module automates and streamlines the end-to-end grants and funding requests for medical education, charitable donations, sponsorships, patient education and other giving programs. From the funding application, approval, and review, through to payment and transparency reporting, this new module allows life sciences companies to accelerate funding requests, eliminate errors, monitor compliance, track payments, and demonstrate the impact of giving programs globally.

“With this launch, IQVIA has further expanded in the engagement management space, transforming grants and funding through streamlined workflows and automated processes. Prior to this launch, there was a need for a global grants solution focused on user experience and outcomes. Leveraging unparalleled compliance expertise, and insight into how quickly regulations change, IQVIA’s newest platform is built to evolve with industry needs, improving business efficiencies,” said Mike Townsend, IDC analyst.

For more information about IQVIA’s latest Grants and Funding Management solution, please visit www.iqvia.com/grants.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 77,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors, and scientific advances, to advance their path toward cures. To learn more, visit www.iqvia.com.

Nick Childs, IQVIA Investor Relations (nicholas.childs@iqvia.com)

+1.973.316.3828



Tor Constantino, IQVIA Media Relations (tor.constantino@iqvia.com)

+1.484.567.6732

Source: IQVIA

FAQ

What is the purpose of IQVIA's new Grants and Funding Management module?

The module provides life sciences companies efficient tools to manage global strategic giving programs, including grant applications and payment processing.

When was the Grants and Funding Management module launched by IQVIA?

IQVIA announced the launch of the Grants and Funding Management module on November 18, 2021.

How does the new module improve the grants management process?

The module automates workflows, reduces errors, and enhances compliance tracking, thereby streamlining the entire grants management process.

Which portfolio does the Grants and Funding Management module belong to?

It is part of IQVIA's Orchestrated Customer Engagement (OCE) solutions portfolio.

IQVIA Holdings Inc.

NYSE:IQV

IQV Rankings

IQV Latest News

IQV Stock Data

44.80B
182.30M
0.92%
94.56%
1.59%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States of America
DURHAM